69
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts

, , Ph.D., Prof., , Ph.D. Prof., , Ph.D., , Ph.D. &
Pages 196-202 | Published online: 01 Apr 2011

REFERENCES

  • Virmani A, Binienda ZK, Ali SF, Gaetani F. Metabolic syndrome in drug abuse. Ann NY Acad Sci 2007; 1122:50–68.
  • Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: Assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Interventions Trial. Am J Cardiol 2000; 86:19–22.
  • Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-I: Risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 2004; 255:188–205.
  • Sniderman AD, Furberg CD, Keech A Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361:777–780.
  • Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008; 31(4):811–822.
  • Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Lancet 2001; 358(9298):2026–2033.
  • Sedigheh A, Nizal S, Gholam-Ali N, Reza R. Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter? Lipids Health Dis 2008; 7:42–47.
  • Mohammadi A, Darbi M, Nasry M. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp Toxicol Pathol 2009; 61(2):145–149.
  • Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N, Karimi AA. The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2007; 14(5):715–717.
  • Brinkman GL, Coates EO, Jr. The effect of bronchitis, smoking and occupation on ventilation. Ann Rev Respir Dis 1964; 87:684–693.
  • Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 1998; 44(8):1641–1649. Journal
  • Wilczek H, Češka R, Zlatohlávek L. Serum lipids in drug addicts. Vnitr Lek 2004; 54(75):898–902.
  • Kalyoncu A, Mırsal H, Pektaş O, Tan D, Beyazyürek M. Heroin-dependent patients attempting and not attempting suicide: A comparison study. Acta Neuropsychiatrica 2007; 19(5):297–303.
  • Maccari S, Bassi C, Zanoni P, Plancher AC. Plasma cholesterol and triglycerides in heroin addicts. Drug Alcohol Depend 1991; 29(2):183–187.
  • Abs P, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000; 85:2215–2222.
  • Saladin R, W-Dac N, Fruchart JC, Auwerx J, Staels B. Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein. Eur J Biochem 1996; 23:451–459.
  • Webster JB, Coupal H, Cushman P, Jr. Increased serum thyroxin levels in euthyroid narcotic addicts. J Clin Endocrinol Metab 1975; 37:928–934.
  • Sokolov EI, Metel’skaia VA, Perova NV, Shchukina GN. Hormonal regulation of lipoprotein metabolism: The role in pathogenesis of coronary heart disease. Kardiologiia 2006; 46(7):4–9.
  • Brenneisen R, Hasler F. GC/MS determination of pyrolysis products from diacetylmorphine and adulterants of street heroin samples. J Forensic Sci 2002; 47(4):885–888.
  • Othman A, Al Sagair OH. Effect of morphine sulfate on total lipids and triglycerides contents in serum and brain regions of rat. Med J Islamic World Acad Sci 2005; 15(3):117–125.
  • Kouros D, Tahereh H, Mohammadreza A, Minoo MZ. Opium and heroin alter biochemical parameters of human’s serum. Am J Drug Alcohol Abuse 2010; 36(3):135–139.
  • Sablé-Amplis R, Agid R, Abadie D. Some effects of morphine on lipid metabolism in normal, tolerant and abstinent rats. Life Sci 1975; 16(9):1477–1482.
  • Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003; 46:459–469.
  • Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005; 28:2181–2186.
  • Housová J, Wilczek H, Haluzík MM, Kremen J, Krízová J, Haluzík M. Adipocyte-derived hormones in heroin addicts: The influence of methadone maintenance treatment. Physiol Res 2005; 54:73–78.
  • Stoermer R, Drewe J, Dursteler-Mac Farland KM, Hock C, Mueller-Spahn F, Ladewig D, Stohler R, Mager R. Safety of injectable opioid maintenance treatment for heroin dependence. Biol Psychiatry 2003; 54(8):854–861.
  • Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoеa is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9):735–741.
  • Rose AJ, Hermos JA, Frayne SM, Pogach LM, Berlowitz DR, Miller DR. Does opioid therapy affect quality of care for diabetes mellitus? Am J Manag Care 2009; 15(4):217–224.
  • Asgary S, Naderi GH, Soghraty M, Ahmady P, Shahrezaee JR. A study of plasma lipid peroxidation, lipids and blood sugar levels in opium addicts compared with control group. ARYA Journal 2005; 1(2):72–74.
  • Rajs J, Petersson A, Thiblin I, Olsson-Mortlock C, Fredriksson A, Eksborg S. Nutritional status of deceased illicit drug addicts in Stockholm, Sweden–A longitudinal medicolegal study. J Forensic Sci 2004; 49(2):320–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.